Domingo Liotta Hospital, Houston, Texas. First Clinical use. 1966 (August 8): Liotta-DeBakey LVAD in a paracorporeal position in cardiogenic shock postcardiotomy, Methodist Hospital, Houston, Texas. First successful clinical use. 1969 (April 4): Liotta-Cooley Total Artificial Heart, Texas Heart Institute, Houston, Texas. First clinical use. http://www.texasheartinstitute.org/Research/Devices/liotta.cfm. This device was stolen from the lab of Dr. Michael E. DeBakey by Liotta. Dr. Cooley was not involved in any way in its development. The device had not been successful in animal experiments, and while the patient had the artificial heart in place he developed multiple system organ failure, as the experimental animals had, and died
Progress in artificial intelligence the field is rarely credited for these successes. Kaplan and Haenlein structure artificial intelligence along three evolutionary stages: 1) artificial narrow intelligence – applying AI only to specific tasks; 2) artificial general intelligence – applying AI to several areas and able to autonomously solve problems they were never even designed for; and 3) artificial super intelligence – applying AI to any area capable of scientific creativity, social skills, and general wisdom. To allow comparison with human performance, artificial intelligence can be evaluated on constrained and well-defined problems. Such tests have been termed subject matter expert Turing tests. Also, smaller problems